Google News Alert for: thyroid
| Mylan Receives FDA Approval for Generic Version of Thyroid ... PR Newswire (press release) - New York,NY,USA Liothyronine Sodium Tablets are the generic version of King Pharmaceuticals' thyroid deficiency treatment Cytomel(R), which had total US sales of ... See all stories on this topic |
| Are Your Hormones Making You Miserable? Huffington Post - New York,NY,USA ... sugar balance through the pancreas to your thyroid hormone via the thyroid gland, to your sexual behavior and function through the reproductive organs. ... See all stories on this topic |
| POLICE PROBE MJ DEATH AS HOMICIDE: LAPD ... Eurweb.com - Los Angeles,CA,USA Dr. William Barnhart "Barney" VanValin, internist and general practitioner, specializing in thyroid problems, staff doctor at the Hormone Resource Center in ... See all stories on this topic |
| Thyroid Cancer Rate on the Rise Ivanhoe - Winter Park,FL,USA (Ivanhoe Newswire) -- Studies have reported a sharp increase in thyroid cancer since 1980. A possible explanation is increased detection through widespread ... See all stories on this topic |
| America plays the blame game Dadeville Record - Alexander City,AL,USA After years of failure, she began to blame her weight problem on her thyroid. I remember very clearly hearing her claim she could eat next to nothing for ... See all stories on this topic |
| Thyroid Cancer Rates are Increasing, and Better Detection is Not ... About - News & Issues - New York,NY,USA Rates of thyroid cancer are on the rise in the United States, and new research shows that the increase is due not just to better detection of existing ... See all stories on this topic |
| Effects of fluoridated water on arthritis, hypothyroidism, kidney ... Examiner.com - USA Here are just some of the potential health threats from fluoride in our diets and our water: arthritis, skeletal fluorosis, thyroid dysfunction, ... See all stories on this topic |
This once a day Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
No comments:
Post a Comment